ACR/ARHP 2016

3 / 20

EDITORIAL
MANAGING EDITOR
Anne Neilson
EDITOR
Carolyn Ng
DESIGNER
Jana Sokolovskaja
SALES
COMMERCIAL MANAGER
Fleur Gill
ACCOUNT MANAGER
Linnea Mitchell-Taverner
DISCLAIMER
The Elsevier Conference Series
provides highlights of key local and
international conferences for specialist
medical professionals. News stories are
independently produced by the Elsevier
Australia editorial team.
The ideas and opinions expressed in this
publication do not necessarily reflect those
of the Publisher. Elsevier Australia will
not assume responsibility for damages,
loss, or claims of any kind arising from or
related to the information contained in this
publication, including any claims related to
the products, drugs, or services mentioned
herein. Because of rapid advances in the
medical sciences, in particular, independent
verification of diagnoses and drug dosages
should be made. Please consult the
full current Product Information before
prescribing any medication mentioned in
this publication.
Although all advertisingmaterial is expected
to conform to ethical (medical) standards,
inclusion in this publication does not
constitute a guarantee or endorsement of
the quality or value of such product or of
the claims made of it by its manufacturer.
ELSEVIER AUSTRALIA
ABN 70 001 002 357
475 Victoria Avenue Chatswood
NSW 2067 Australia
Locked Bag 7500
Chatswood DC NSW 2067
© 2016 Elsevier Inc.
EMCS121601
Welcome to our special coverage of the American College of
Rheumatology and Association of Rheumatology Health
Professionals Annual Meeting, part of the Elsevier Conference
Series, that aims to bring you key clinical and scientific news from the
world’s top medical congresses.
This special ACR/ARHP 2016 Annual Meeting, kindly brought to you
through advertising by Janssen Australia, brings together leading research
from the top guns who are changing paradigms in rheumatology. Our
Elsevier Australia news team has independently reported from the 4000
poster and oral presentations on show to bring you the best ACR/ARHP
2016 Annual Meeting, has to offer.
Topics, we selected, that are creating this paradigm shift include:
• New thinking on biologics in RA
• Use of DMARDs through RA surgery
• Intensive management regimes to reduce RA disease activity
• Importance of early diagnosis and treatment for RA remission
• Increased CV risk for RA patients
• Emergence of gene expression signatures, and
• Promise of Wnt inhibitors in OA
We hope you enjoy this issue of the Elsevier Conference Series.
Anne Neilson
Managing Editor
Elsevier Conference Series
Changing paradigms in
rheumatology
© ACR/ARHP 2016 Annual Meeting •
EDITORIAL
ACR/ARHP 2016 Annual Meeting • Elsevier Conference Series 3